Wednesday, May 18, 2016

UPDATE 1-U.S. FDA approves Roche's immunotherapy for bladder cancer

May 18 (Reuters) - The U.S. Food and Drug Administration on

Wednesday granted accelerated approval for Roche Holding AG's

immunotherapy for the most common form of bladder

cancer, marking the...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)